Skip to content
lifestyle.cfxmagazine.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
NEURIZON THERAPEUTICS LIMITED
HEALEY ALS Platform Trial Regimen I enrolment completed – Topline results for NUZ-001 accelerated to Q2 CY2027
July 17, 2026
HEALEY ALS Platform Trial Regimen I expands to 240 participants
May 27, 2026
Neurizon Initiates Dosing of NUZ-001 in HEALEY ALS Platform Trial
February 26, 2026